---
title: "Distinct pathway-based effects of blood pressure and body mass index on cardiovascular traits: comparison of novel Mendelian randomization approaches"
description: |
  * **Objective**: This study introduced a **novel pathway-partitioned Mendelian randomization (MR) approach** (based on proximity to Mendelian disease genes) and compared its findings to the existing **tissue-partitioned MR** approach for **Blood Pressure (BP)** and **Body Mass Index (BMI)** effects on cardiovascular traits.
  * **BP Findings**: The pathway-partitioned MR showed that **renal-system related IVs** were significantly associated with **Coronary Artery Disease (CAD)**, while **vascular-related IVs** were significantly associated with **Stroke**, demonstrating distinct causal pathways.
  * **BMI Findings**: Both the pathway-partitioned (Mental Health vs. Metabolic) and tissue-partitioned (Brain vs. Adipose) methods for BMI consistently found that genetic variants related to **central/appetite regulation** had a **stronger causal effect** on the risk of **Type 2 Diabetes Mellitus (T2DM)**.
date: last-modified
categories: [blood pressure, body mass index, genetic heterogeneity, mendelian randomization, pathway analysis, tissue specificity]
---

**PubMed:** [40375348](https://pubmed.ncbi.nlm.nih.gov/40375348/)
**DOI:** [10.1186/s13073-025-01472-2](https://doi.org/10.1186/s13073-025-01472-2)
**Overview generated by:** Gemini 2.5 Flash, 28/11/2025

## Key Findings: Comparing MR Partitioning Approaches

This study introduces a **novel pathway-partitioned Mendelian randomization (MR) approach** and compares its performance and findings against an existing **tissue-partitioned MR approach** to dissect the heterogeneous genetic effects of **Blood Pressure (BP)** and **Body Mass Index (BMI)** on downstream cardiovascular traits.

* **Pathway-Partitioned MR is Effective:** The novel pathway-partitioned approach successfully isolated sets of genetic instruments based on their proximity to genes implicated in Mendelian disorders of the **renal system** or **vasculature** (for BP), or **mental health** or **metabolic disorders** (for BMI).
* **Distinct Causal Pathways for BP:**
    * **Renal Pathway:** Genetic instruments related to the **renal system** were significantly and strongly associated with a causal risk of **Coronary Artery Disease (CAD)**.
    * **Vascular Pathway:** Genetic instruments related to the **vasculature** were significantly and strongly associated with a causal risk of **Stroke**.
* **Confirmation of BMI Pathways:** The pathway-partitioned MR for BMI (Mental Health vs. Metabolic disorders) largely **confirmed the findings** of the previously developed tissue-partitioned approach (Brain vs. Adipose tissue). Both methodologies consistently showed that genetic variants related to **central/appetite regulation** (Mental Health/Brain-mediated) had a **stronger causal effect** on **Type 2 Diabetes Mellitus (T2DM)** risk compared to the metabolic/peripheral pathways.
* **Complementary Methods:** The study concludes that both the pathway-partitioned and tissue-partitioned MR methods are valid, complementary tools for disentangling the genetic heterogeneity of complex traits, offering more granular insights into disease mechanisms than conventional MR which uses a single, aggregated instrument set.

## Study Design and Methods

### Study Design

The study employed a **two-sample Mendelian randomization (MR)** design, introducing a new method for partitioning genetic instrumental variables (IVs) and comparing it against a previous method (tissue-partitioned MR). The analysis was conducted using both individual-level (UK Biobank) and summary-level MR methodologies.

### Instrument Partitioning Approaches

1.  **Pathway-Partitioned MR (Novel Method):**
    * **Mechanism:** SNPs were partitioned based on their proximity to genes associated with specific **Mendelian diseases** known to affect the trait.
    * **BP Partitioning:** IVs were grouped into **Renal System** (e.g., genes causing monogenic hypertension/kidney disease) and **Vasculature** (e.g., genes causing monogenic vascular disorders).
    * **BMI Partitioning:** IVs were grouped into **Mental Health** (genes implicated in psychiatric/neurodevelopmental disorders, often affecting appetite) and **Metabolic** disorders (genes linked to monogenic obesity/metabolic conditions).
2.  **Tissue-Partitioned MR (Existing Method):**
    * **Mechanism:** SNPs were partitioned based on genetic colocalization and causal association with gene expression in **contrasting tissues**.
    * **BMI Partitioning:** IVs were grouped into **Brain-mediated** and **Adipose-mediated** sets, mirroring the previous study by the same authors.

### Data Sources and Outcomes

* **Exposure GWAS:** Summary statistics for BP and BMI were sourced from large, publicly available consortia (e.g., UK Biobank, GIANT).
* **Outcome GWAS:** Cardiometabolic outcomes included **CAD**, **Stroke** (all subtypes), and **T2DM**.

### Statistical Analysis

* **MR Methods:** The **Inverse-Variance Weighted (IVW)** method was the primary technique for estimating causal effects within each partitioned gene set. This was supplemented by sensitivity analyses (e.g., MR-Egger, Weighted Median).
* **Comparison:** The causal effect estimates (e.g., Odds Ratios, ORs) derived from the different pathway/tissue partitions were compared using formal statistical tests to determine if the effect estimates were significantly different from each other.

## Conclusions and Recommendations

This research validates the use of partitioning complex trait instruments into biologically meaningful subgroups to gain clearer etiological insights.

* **Enhanced Mechanistic Detail:** By distinguishing between genetic variants acting on the renal system versus the vasculature for BP, the study provides targets for both **CAD and Stroke prevention** that were not possible with an aggregated BP instrument.
* **Therapeutic Prioritization:** The consistent finding across both partitioning methods for BMI—that appetite-regulating pathways have a disproportionate effect on T2DM risk—strongly supports **therapeutic targeting of central regulation** for T2DM prevention in at-risk individuals.
* **Future Application:** The authors propose that the pathway-partitioned approach, being data-driven and leveraging established Mendelian disease classifications, offers a valuable, **mechanistic complement** to tissue-based MR for dissecting the genetic architecture of other complex diseases.